GT Medical Technologies Stock

GT Medical Technologies provides surgically targeted radiation therapy to individuals with operable brain tumors.

Sign up today and learn more about GT Medical Technologies Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About GT Medical Technologies Stock

GT Medical Technologies, an Arizona-based medical device company, is focused on improving the lives of patients with brain tumors. GT has developed an innovative approach to treatment by combining a conformable collagen matrix with brachytherapy (radiation) seeds. The company's first product, GammaTile™ is protected by 10 US and 2 Canadian-issued patents, and 1 EPO patent. The product has the promise to revolutionize treatment for 176,000 patients/year in the US alone. To date, we have treated 120 patients with recurrent brain tumors in a clinical trial at Barrow Neurological Institute (BNI) and observed significant clinical improvement.

Funding History

January 2018$3.0M
January 2019$10.0M
November 2020$16.0M
March 2023$45.0M

Management

Vice President Marketing

Jane Steen

Vice President Clinical Affairs

Lisa Misell

VP of Strategy and Corporate Development & Officer of the Board

Brian Martin

Co-Founder

Peter Nakaji

President & CEO

Matthew E. Likens

Co-Founder

Heyoung McBride

Board Member

Kyle Dempsey

President

Shane Brown

Co-Founder and CTO

David Brachman

Co-Founder

Theresa Thomas

Press

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo